Stage FocusSeries A, Series B+
GeographyChina
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAISemiconductorsAdvanced ManufacturingHardwareBuilt EnvironmentAdvanced Materials
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Shenzhen Oriental Fortune Capital is a major Chinese VC managing ¥20B+ (RMB) since 2006, with a portfolio of 500+ companies and 100+ IPO exits. The fund focuses on healthcare, biopharma, medical devices, and life sciences while also being active in hard tech sectors including semiconductors, advanced manufacturing, and new materials.
Government-backed with deep connections to the Shenzhen ecosyst...
Notable Investments
F
Fosun PharmaW
Walvax BiotechnologySimilar Funds
Parkwalk Advisors
London, United Kingdom
DeepTech NativeBiotechAIQuantumSeedSeries A
M Ventures (Merck)
Amsterdam, Netherlands
DeepTech NativeBiotechSemiconductorsAdvanced MaterialsSeedSeries A
Osage University Partners
Bala Cynwyd, United States
DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Vickers Venture Partners
Singapore
DeepTech NativeBiotechAIClimate TechSeries ASeries B+
BGF
London, United Kingdom
GeneralistBiotechClimate TechAdvanced MaterialsSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A